AQR Capital Management »

Elevation Oncology shares owned by AQR Capital Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $97k 161k 0.60

More positions owned by AQR Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Zoom Communications Cl A (ZM)
Ge Aerospace Com New (GE)
Cme (CME)
Alphabet Cap Stk Cl C (GOOG)
Merck & Co (MRK)
McKesson Corporation (MCK)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)

View all positions for AQR Capital Management

Top funds holding Elevation Oncology

Frazier Life Sciences Management
Tang Capital Management
Farallon Capital Management
BlackRock
BVF
Aisling Capital Management
Vanguard Group
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Sphera Funds Management
OrbiMed Advisors
Millennium Management
Ikarian Capital

View all funds holding Elevation Oncology